Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China

August 24, 2015 updated by: Xinghui Liu, West China Second University Hospital
The purpose of this study is to build a model for the prediction of adverse perinatal outcome for preeclampsia in china

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Chinese women who fulfilled a research definition of preeclampsia, and who were admitted to participating obstetric centres

Description

Inclusion Criteria:

  • admitted with preeclampsia or had developed preeclampsia after admission

Exclusion Criteria:

  • admitted in spontaneous labour or had achieved any component of the maternal outcome before either fulfilling eligibility criteria or collection of predictor data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
maternal mortality
Time Frame: within 48h of eligibility
within 48h of eligibility

Secondary Outcome Measures

Outcome Measure
Time Frame
serious central nervous system morbidity
Time Frame: within 48h of eligibility
within 48h of eligibility
serious cardiorespiratory morbidity
Time Frame: within 48h of eligibility
within 48h of eligibility
serious hepatic morbidity.
Time Frame: within 48h of eligibility
within 48h of eligibility
serious renal morbidity
Time Frame: within 48h of eligibility
within 48h of eligibility
serious haematological morbidity
Time Frame: within 48h of eligibility
within 48h of eligibility

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2016

Primary Completion (Anticipated)

December 1, 2016

Study Registration Dates

First Submitted

March 1, 2013

First Submitted That Met QC Criteria

March 1, 2013

First Posted (Estimate)

March 5, 2013

Study Record Updates

Last Update Posted (Estimate)

August 25, 2015

Last Update Submitted That Met QC Criteria

August 24, 2015

Last Verified

June 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • hx2ck2

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preeclampsia

Subscribe